HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Variable electrocardiographic effects of short-term quinidine sulfate administration in Brugada syndrome.

Abstract
Quinidine, a class I antiarrhythmic agent with blocking property of transient outward current, is a possible candidate for the suppression of ventricular fibrillation in patients with Brugada syndrome; although there is a concern that its ability to these effects may be proarrhythmic. Therefore, we evaluated the effect of quinidine sulfate on ST-segment elevation in Brugada syndrome. In 8 patients with Brugada syndrome, the magnitude of ST-elevation at the J-point (ST(J)), and the ST-segment configuration in leads V1-V3, were compared before and on day 2 after the initiation of quinidine administration. In 3 patients, quinidine attenuated ST(J) by > or = 0.1 mV. Of these 3 patients, ST-segment elevation was normalized in 2 patients, while the ST-segment configuration was unchanged in another. In another 3 patients, quinidine augmented ST(J) by > or = 0.1 mV without any change of ST-segment configuration, and the augmentation was returned to baseline after the discontinuation of quinidine. Quinidine exhibited no effect on the ST-segment in the remaining 2 patients. The favorable effects of quinidine on the ST-segment tended to be more pronounced in patients with prominent ST-elevation at baseline. In 1 patient, quinidine was effective in eliminating both ST-segment elevation and repetitive tachyarrhythmia episodes. In conclusion, the effects of quinidine on ST-segment elevation were variable. Quinidine may potentially augment the ST-segment elevation in some patients with Brugada syndrome.
AuthorsHiroshi Watanabe, Masaomi Chinushi, Takashi Washizuka, Hirotaka Sugiura, Takashi Hirono, Satoru Komura, Yukio Hosaka, Masayuki Yamaura, Yasutaka Tanabe, Hiroshi Furushima, Satoru Fujita, Yoshifusa Aizawa
JournalPacing and clinical electrophysiology : PACE (Pacing Clin Electrophysiol) Vol. 28 Issue 5 Pg. 372-7 (May 2005) ISSN: 0147-8389 [Print] United States
PMID15869667 (Publication Type: Journal Article)
Chemical References
  • Anti-Arrhythmia Agents
  • Quinidine
Topics
  • Adult
  • Aged
  • Anti-Arrhythmia Agents (administration & dosage)
  • Bundle-Branch Block (physiopathology)
  • Electrocardiography (drug effects)
  • Female
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Quinidine (administration & dosage)
  • Syncope
  • Syndrome
  • Ventricular Fibrillation (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: